Join
Live feed
·
PRReleasevia Quantisnow
Profusa Inc. logo

Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches

ByQuantisnow·Wall Street's wire, on your screen.
PFSA· Profusa Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PFSA (Profusa Inc.) and more on Quantisnow.